Prognostic value of venous tumor thrombus in renal cell carcinoma - Abstract

Servicio de Urología, Hospital Universitario y Politécnico La Fe, Valencia, España.

 

To evaluate the prognostic value of venous tumor thrombus in renal cell carcinoma.

A retrospective study of 167 patients with renal cell carcinoma and stage pT3 who underwent radical nephrectomy and extended lymphadenectomy from July 1969 to May 2008 was conducted. Patients with any kind of venous involvement were selected for the analysis (73 patients; 43.7%). The Kaplan Meier survival curves and log-rank test for comparisons were used for the survival analysis. Multivariate analysis was done by Cox regression.

Lymph node involvement was present in 30 patients (41.1%) and metastatic disease in 9 patients (12.3%). The most frequent histologic renal cell carcinoma subtype was 50 (68.5%) conventional carcinoma, followed by nondifferentiated in 11 (15.5%), and chromophobe in 9 (12.3%). High grade tumors (Furhman 3-4) were present in 57% of the cases. Venous thrombus level extended to renal vein in 61 patients (83.6%), to inferior vena cava in 9 patients (12.3%) and to the cardiac right atrium in 3 cases (4.1%). The survival analysis showed worse survival in those patients with venous tumor thrombosis (p=.001) and with vein wall invasion (p=.0042), but not in function on the level of the thrombus (p=.12). The multivariate analysis identified the Furhman grade and venous tumor thrombosis as independent survival prognostic factors.

In our series, venous tumor thrombosis, together with the Furhman nuclear grade, is an independent survival prognostic factor. However, neither cephalic extension of the thrombus nor the invasion of the vein wall showed independent prognostic value.

Article in English, Spanish.

Written by:
García-Fadrique G, Budía-Alba A, Ruiz-Cerdá JL, Morales-Solchaga G, Pontones JL, Jiménez-Cruz JF.   Are you the author?

Reference: Actas Urol Esp. 2011 Jul 28. Epub ahead of print.
doi: 10.1016/j.acuro.2011.06.00

PubMed Abstract
PMID: 21802784

UroToday.com Renal Cancer Section